Skip to main content

Peer Review reports

From: Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer

Original Submission
14 Nov 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
13 Dec 2023 Reviewed Reviewer Report
17 Jan 2024 Reviewed Reviewer Report
30 Jan 2024 Author responded Author comments - Xiangjiao Meng
Resubmission - Version 3
30 Jan 2024 Submitted Manuscript version 3
31 Jan 2024 Author responded Author comments - Xiangjiao Meng
Resubmission - Version 4
31 Jan 2024 Submitted Manuscript version 4
9 Feb 2024 Reviewed Reviewer Report
24 Mar 2024 Reviewed Reviewer Report - Aliaksandr Skrahin
30 Mar 2024 Author responded Author comments - Xiangjiao Meng
Resubmission - Version 5
30 Mar 2024 Submitted Manuscript version 5
3 Apr 2024 Reviewed Reviewer Report
4 Apr 2024 Reviewed Reviewer Report - Aliaksandr Skrahin
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
5 Apr 2024 Editorially accepted
17 Apr 2024 Article published 10.1186/s12885-024-12228-3

You can find further information about peer review here.

Back to article page